BACTERIAL VAGINOSIS AND ANTIMICROBIAL ACTIVITY DURING PREGNANCY


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Objective. To compare the antimicrobial activity of vaginal discharge with the nature of bacterial vaginosis, vaginal pH, and microbiological indicators. Subjects and methods. The investigation enrolled 53 pregnant women, of whom 34 were diagnosed with bacterial vaginosis and 19 were with normal vaginal microbiocenosis. The severity of bacterial vaginosis was estimated from the total scores using a combination of clinical symptoms: itching, burning, the nature and amount of discharge, pain during urination, dyspareunia, perianal dermatitis, swelling, hyperemia, and erosive lesions of the vaginal walls. Vaginal discharge samples were examined to determine the antimicrobial activity of the vaginal epithelium. The antibacterial activity of antimicrobial peptides was determined in the groups of pregnant women depending on the nature of clinical symptoms of bacterial vaginosis. Results. Production of the endogenous antibiotics antimicrobial peptides provides adequate protection against infectious agents. The lowered activity of antimicrobial peptides leads to a quantitative increase in the facultative vaginal microflora and to the depletion of the obligate microflora, which contributes to the more pronounced clinical course of bacterial vaginosis. Conclusion. To expand diagnostic parameters in the set of examinations of pregnant women with inflammatory and dysbiotic disorders in the lower reproductive tract, by including the indicators of systemic and local immunity along with microbiological monitoring and an integrated assessment of the vaginal microbiocenosis, will be able to personify therapeutic approaches for each individual patient.

Full Text

Restricted Access

About the authors

Tamara E. Karapetyan

National Medical Research Center of Obstetrics, Gynecology, and Perinatology Academician named after V.I. Kulakov, Ministry of Health of Russia

Email: t_karapetyan@oparina4.ru
MD, senior researcher of the obstetrics department Moscow 117997, Ac. Oparina str. 4, Russia

Vera G. Arzumanyan

I.I. Mechnikov Research Institute of Vaccines and Sera, Russian Academy of Medical Sciences

Email: mech.inst@mail.ru
PhD, MD Moscow 105064, Malyj Kazennyj pereulok, 5A, Russia

Victor L. Tyutyunnik

National Medical Research Center of Obstetrics, Gynecology, and Perinatology Academician named after V.I. Kulakov, Ministry of Health of Russia

Email: tioutiounnik@mail.ru
PhD, MD, the head of the obstetric physiological department Moscow 117997, Ac. Oparina str. 4, Russia

Natalia E. Kan

National Medical Research Center of Obstetrics, Gynecology, and Perinatology Academician named after V.I. Kulakov, Ministry of Health of Russia

Email: kan-med@mail.ru
PhD, MD, the head of the obstetric department Moscow 117997, Ac. Oparina str. 4, Russia

Natalia A. Lomova

National Medical Research Center of Obstetrics, Gynecology, and Perinatology Academician named after V.I. Kulakov, Ministry of Health of Russia

Email: n_lomova@oparina4.ru
PhD, researcher of the obstetric department Moscow 117997, Ac. Oparina str. 4, Russia

Anna A. Kanyukina

A.I. Evdokimov Moscow State University of Medicine and Dentistry

Email: ya.friend@yandex.ru
a student Moscow 127473, Delegatskaya str. 20/1, Russia

References

  1. Nelson D.B., Rockwell L.C., Prioleau M.D., Goetzl L. The role of the bacterial microbiota on reproductive and pregnancy health. Anaerobe. 2016; 42: 67-73.
  2. Cavera V.L., Volski A., Chikindas M.L. The natural antimicrobial subtilosin A synergizes with Lauramide Arginine Ethyl Ester (LAE), e-poly-L-lysine (Polylysine), clindamycin phosphate and metronidazole, against the vaginal pathogen Gardnerella vaginalis. Probiotics Antimicrob. Proteins. 2015; 7(2): 164-71.
  3. Анкирская А.С., Муравьева В.В. Опыт микробиологической диагностики оппортунистических инфекций влагалища. Клиническая микробиология и антимикробная химиотерапия. 2001; 3(2): 190-4.
  4. Doerflinger S.Y., Throop A.L., Herbst-Kralovetz M.M. Bacteria in the vaginal microbiome alter the innate immune response and barrier properties of the human vaginal epithelia in a species-specific manner. J. Infect. Dis. 2014; 209(12): 1989-99.
  5. Mitchell C., Gottsch M.L., Liu C., Fredricks D.N., Nelson D.B. Associations between vaginal bacteria and levels of vaginal defensins in pregnant women. Am. J. Obstet. Gynecol. 2013; 208(2): 132. e1-7.
  6. Rittenschober-Böhm J., Waldhoer T., Schulz S.M., Stihsen B., Pimpel B., Goeral K. et al. First trimester vaginal ureaplasma biovar colonization and preterm birth: results of a prospective multicenter study. Neonatology. 2018; 113(1): 1-6.
  7. Hoffman M.K., Bellad M.B., Charantimath U.S., Kavi A., Nagmoti J.M., Nagmoti M.B. et al. A comparison of colorimetric assessment of vaginal pH with nugent score for the detection of bacterial vaginosis. Infect. Dis. Obstet. Gynecol. 2017; 2017: 1040984.
  8. Nwankwo T.O., Aniebue U.U., Umeh U.A. Syndromic diagnosis in evaluation of women with symptoms of vaginitis. Curr. Infect. Dis. Rep. 2017; 19(1): 3.
  9. Redelinghuys M.J., Ehlers M.M., Bezuidenhoudt J.E., Becker P.J., Kock M.M. Assessment of Atopobium vaginae and Gardnerella vaginalis concentrations in a cohort of pregnant South African women. Sex. Transm. Infect. 2017; 93(6): 410-5.
  10. Haahr T., Ersboll A.S., Karlsen M.A., Svare J., Sneider K., Hee L. et al. Appreciable uncertainty regarding benefits and risks in the treatment of bacterial vaginosis to prevent preterm birth. Acta Obstet. Gynecol. Scand. 2017; 96(2): 251-2.
  11. Lamont R.F., Keelan J.A., Larsson P.G., Jorgensen J.S. The treatment of bacterial vaginosis in pregnancy with clindamycin to reduce the risk of infection-related preterm birth: a response to the Danish Society of Obstetrics and Gynecology guideline group’s clinical recommendations. Acta Obstet. Gynecol. Scand. 2017; 96(2): 139-43.
  12. Catallozzi M., Fraiz L.D., Hargreaves K.M., Zimet G.D., Stanberry L.R., Ratner A.J. et al. Pregnant women’s attitudes about topical microbicides for the prevention and treatment of bacterial vaginosis during pregnancy. Int. J. STD AIDS. 2017; 28(9): 881-6.
  13. Хрянин А.А., Решетников О.В. Бактериальный вагиноз. Новая парадигма. Акушерство и гинекология. 2016; 4: 133-9.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2018 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies